Catalogo dei prodotti della ricerca

MARINELLI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 809
NA - Nord America 612
AS - Asia 237
AF - Africa 9
SA - Sud America 5
Totale 1.672
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 593
IT - Italia 381
SE - Svezia 277
SG - Singapore 155
DE - Germania 36
IN - India 30
FI - Finlandia 26
CN - Cina 25
ID - Indonesia 19
GB - Regno Unito 15
BG - Bulgaria 14
CA - Canada 13
IE - Irlanda 11
NL - Olanda 9
RU - Federazione Russa 9
TG - Togo 8
MX - Messico 5
AT - Austria 4
BE - Belgio 4
FR - Francia 4
RO - Romania 4
ES - Italia 3
IR - Iran 3
UA - Ucraina 3
CO - Colombia 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
LT - Lituania 2
PH - Filippine 2
AL - Albania 1
AR - Argentina 1
CH - Svizzera 1
CL - Cile 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
IL - Israele 1
PT - Portogallo 1
VA - Santa Sede (Città del Vaticano) 1
ZA - Sudafrica 1
Totale 1.672
Salva come PNG Salva come JPEG
Città #
Stockholm 175
Rome 156
Singapore 113
Santa Clara 69
Chandler 65
Fairfield 65
Ashburn 29
Boardman 28
Milan 27
Helsinki 24
Princeton 22
Jakarta 19
San Paolo di Civitate 15
New York 14
Sacramento 14
Sofia 14
Seattle 13
Wilmington 13
Woodbridge 13
Cambridge 12
Millbury 12
Houston 11
Turin 11
Andover 10
San Diego 10
Boston 9
Bremen 9
Dublin 9
Lawrence 9
Naples 9
Ann Arbor 8
Lomé 8
Padova 8
Florence 7
Toronto 7
Moscow 5
Brussels 4
Catania 4
Falkenstein 4
Los Angeles 4
Norwalk 4
Ottawa 4
Dallas 3
Frankfurt am Main 3
Mannheim 3
Mexico City 3
Albignasego 2
Amsterdam 2
Arezzo 2
Beijing 2
Boydton 2
Brescia 2
Brugherio 2
Bühl 2
Calvanico 2
Carignano 2
Cartagena 2
Castelnuovo di Porto 2
Central 2
Des Moines 2
Formia 2
Fuzhou 2
Genoa 2
Hangzhou 2
Kunming 2
Lanciano 2
Lappeenranta 2
Livorno 2
London 2
Magenta 2
Manchester 2
Messina 2
Miramar 2
Misterbianco 2
Montréal 2
Munich 2
Nuremberg 2
Pescara 2
Pomezia 2
Rapolla 2
Ravenna 2
Rosora 2
San Antonio 2
Silea 2
Vallefoglia 2
Varedo 2
Vienna 2
Zhengzhou 2
Ancona 1
Arrecife 1
Avellino 1
Azor 1
Barcelona 1
Bentivoglio 1
Bern 1
Binghamton 1
Birmingham 1
Cheyenne 1
Collegno 1
Corridonia 1
Totale 1.174
Salva come PNG Salva come JPEG
Nome #
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 189
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease 72
127P {RAS}, {RAF} and {NF}1 oncogenic mutations in {KRAS}-mutated lung adenocarcinoma 69
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden 64
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 64
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study 62
KEAP1 and TP53 frame genomic, evolutionary and immunological subtypes of lung adenocarcinoma with different sensitivity to immunotherapy 62
Neoadjuvant immune-checkpoint blockade in triple-negative breast cancer: current evidence and literature-based meta-analysis of randomized trials 61
Comparison of two blood-based genotyping tests to investigate the KRAS G12C mutation in patients with non-small-cell lung cancer at failure of first-line treatments 58
CDKN2A/B gene loss and MDM2 alteration as a potential molecular signature for hyperprogressive disease in advanced NSCLC: A next-generation-sequencing approach 56
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes 55
The potential role of genomic signature in stage II relapsed colorectal cancer (CRC) patients: a mono-institutional study 49
3MO Oncogenic non-G12C {KRAS} mutations in {KRAS} G12C mutated lung adenocarcinomas in {TRACERx} and {GENIE}: A reservoir for intrinsic resistance to {KRAS} G12C inhibitors 49
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives 48
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience 48
Analysis of molecular biomarkers in resected early-stage non-small cells lung cancer: a narrative review 47
Nodal upstaging evaluation after robotic-assisted lobectomy for early-stage non-small cell lung cancer compared to video-assisted thoracic surgery and thoracotomy: a retrospective single center analysis 44
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 44
Observational multicenter study on the prognostic relevance of coagulation activation in risk assessment and stratification in locally advanced breast cancer. Outline of the arias trial 42
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis 41
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study 40
Circulating hpv dna in the management of oropharyngeal and cervical cancers: current knowledge and future perspectives 38
Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence 38
Prospective assessment of targeted symptom management on supportive care in cancer: An observational cohort study 35
KEAP1-NFE2L2 Mutations in NSCLC: Increased Awareness Needed. Reply to “KEAP1-NFE2L2–Mutant NSCLC and Immune Checkpoint Inhibitors: A Large Database Analysis” 31
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials 30
167P Molecular analysis of gastrointestinal stromal tumor (GIST): The experience of Regina Elena National Cancer Institute 29
Burnout of health care providers during the covid-19 pandemic: Focus on medical oncologists 26
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study 25
Neoadjuvant endocrine therapy in breast cancer. Current knowledge and future perspectives 25
Immunotherapy-Based Combinations in First-Line Urothelial Cancer: A Systematic Review and Individual Patient Data (IPD) Meta-Analysis 21
null 21
Prognostic relevance of neutrophil to lymphocyte ratio (Nlr) in luminal breast cancer: A retrospective analysis in the neoadjuvant setting 21
56P The prognostic role of {KRAS} mutations in patients with early-stage lung adenocarcinoma after robotic lobectomy and systematic lymphadenectomy 20
86P {KRAS} G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma 20
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 20
TRF2 and VEGF-A: An unknown relationship with prognostic impact on survival of colorectal cancer patients 19
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study 19
KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma 18
Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience 17
Palliative sedation and time to death in home palliative care. Retrospective analysis 16
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis 16
Systemic treatment of mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer-single versus double checkpoint inhibition 13
Transcriptional phenocopies of deleterious KEAP1 mutations correlate with survival outcomes in lung cancer treated with immunotherapy 10
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study 9
Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease 8
Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC 8
Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-Analysis 7
11P Reconstructing tumour evolution of single cells using both somatic mutations and copy-number alterations 6
Training and telemedicine: the key to the palliative medicine specialist shortage? 5
Abstract PR010: Linking proliferation rate to the evolution of single-cell primary and metastatic tumor clones 4
Characterizing the evolutionary dynamics of cancer proliferation in single-cell clones with SPRINTER 2
Totale 1.841
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.664
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 0 9 2 7 0 1
2020/2021104 0 1 0 3 2 1 6 16 15 51 9 0
2021/2022259 12 0 3 12 51 17 7 15 16 8 72 46
2022/2023423 88 63 38 35 65 31 9 32 21 22 15 4
2023/2024356 13 27 21 32 36 60 12 26 1 37 42 49
2024/2025680 213 67 92 91 114 101 2 0 0 0 0 0
Totale 1.841